TY - JOUR A1 - Engler, Jennifer A1 - Güthlin, Corina A1 - Bertram, Laura A1 - Tesky, Valentina A1 - Schall, Arthur A1 - Joos, Stefanie A1 - Valentini, Jan T1 - General practitioners’ communication on complementary and integrative medicine for cancer patients: findings from an analysis of consultations with standardised patients T2 - European journal of cancer care N2 - Objective: Our aim was to explore whether general practitioners (GPs) communicate with cancer patients on complementary and integrative medicine (CIM) in a patient-centred and case-specific manner. Methods: We designed two cases of standardised breast cancer patients and allocated 29 GPs to hold a consultation either with Case 1 or Case 2. Case 1 presented with fears of possible physical side effects of hormone treatment. Case 2 feared a loss in social functioning because of nausea and emesis as possible side effects of chemotherapy. Consultations were audiotaped and analysed using the Roter Interaction Analysis System (RIAS). We analysed whether recommended CIM treatments and GPs' focus on psychosocial or medical and therapy-related content differed according to whether they were counselling Case 1 or Case 2. Results: In consultations with Case 1, GPs rather focused on medical and therapy-related content and most often recommended mistletoe, diets and sports. In contrast, GPs focused on psychosocial content and they most often recommended methods of self-care when counselling Case 2. Conclusion: The GPs in our sample reacted case-specifically to the patients' interest in CIM. Such responsive and patient-centred communication is a valuable resource but is often time-consuming. Adequate training and reimbursement should therefore be considered for GPs. KW - cancer KW - complementary medicine KW - counselling KW - general practitioners KW - integrative medicine KW - patient-centred care Y1 - 2022 UR - http://publikationen.ub.uni-frankfurt.de/frontdoor/index/index/docId/73503 UR - https://nbn-resolving.org/urn:nbn:de:hebis:30:3-735032 SN - 1365-2354 N1 - This work was supported by Deutsche Krebshilfe under Grant 70112513. N1 - Open Access funding enabled and organized by Projekt DEAL. VL - 31 IS - 6, art. e13651 SP - 1 EP - 10 PB - Hindawi Limited CY - London ER -